2-(4,4-DIFLUORO-1-PIPERIDINYL)-6-METHOXY-7-(3-(1-PYRROLIDINYL)PROPOXY)-N-(TETRAHYDRO-2H-PYRAN-4-YL)-4-QUINAZOLINAMINE
UNII FF5TQW99D9
Substance Identification & Data
This profile provides standardized clinical and technical data for 2-(4,4-difluoro-1-piperidinyl)-6-methoxy-7-(3-(1-pyrrolidinyl)propoxy)-n-(tetrahydro-2h-pyran-4-yl)-4-quinazolinamine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) FF5TQW99D9.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2761292-40-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C26H37F2N5O3 KUQQSCNRPNSIJK-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 2-(4,4-difluoro-1-piperidinyl)-6-methoxy-7-(3-(1-pyrrolidinyl)propoxy)-n-(tetrahydro-2h-pyran-4-yl)-4-quinazolinamine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.